Hexarelin vs Wolverine Stack
Well Studied vs Well Studied
synergistic Mechanism-based · 47% Hexarelin and Wolverine Stack work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.
Molecular Data
Hexarelin Wolverine Stack
Weight 887 Da N/A
Half-life 1-2 hours —
Chain 6 amino acids N/A
Type Synthetic hexapeptide Peptide blend
Key Benefits
Hexarelin
01 Most potent GHRP for GH stimulation
02 Powerful synergy with GHRH peptides
03 Cardioprotective effects via CD36 receptor
04 Enhanced muscle growth and strength
05 Improved fat metabolism
06 Better recovery and tissue repair
07 Maintains natural GH pulsatility
08 Stable against proteolytic enzymes
Wolverine Stack
01 Complementary healing mechanisms
02 87.5% improvement in knee pain patients
03 Reduced inflammation and enhanced cell migration
04 Promotes angiogenesis and reduces scarring
Dosing Protocols
Hexarelin
100-200 mcg per injection / 2-3 times daily for optimal GH pulses
GH optimization 100 mcg 2-3x daily
Enhanced results 200 mcg 2-3x daily
With GHRH (synergy) 100 mcg each 2-3x daily
Cardioprotection 100-200 mcg 1-2x daily
Wolverine Stack
BPC-157: 250-500 mcg per dose + TB-500: 2-2.5 mg per dose / BPC-157: 1-2x daily; TB-500: 2x per week (typically Monday/Thursday or Tuesday/Friday)
General Recovery Protocol BPC-157: 250mcg 2x/day + TB-500: 2mg 2x/week BPC-157 daily, TB-500 twice weekly
Intensive Injury Recovery BPC-157: 500mcg 2x/day + TB-500: 2.5mg 2x/week BPC-157 daily, TB-500 twice weekly
Maintenance/Prevention Protocol BPC-157: 250mcg 1x/day + TB-500: 2mg 1x/week BPC-157 daily, TB-500 weekly
Side Effects
Hexarelin
Increased appetite (less than GHRP-6)
Water retention
Tingling or numbness
Tiredness after injection
Mild headache
Wolverine Stack
Not extensively documented in human studies
Generally well-tolerated in available research
Contraindications
Active cancer or history of cancer
Pregnancy or breastfeeding
Pituitary disorders
WADA prohibited for competitive athletes
ANY history of cancer or suspicious growths
Active malignancy or concurrent chemotherapy
Pregnancy or breastfeeding
Research Evidence
Hexarelin Wolverine Stack
Status Well Studied Well Studied
References 4 studies 6 studies
Latest — 2025
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.